Home Physical Sciences Chapter 6 Precision oncology: nanoemulsions as pioneers in the delivery of anticancer agents, immunomodulators, and vaccines
Chapter
Licensed
Unlicensed Requires Authentication

Chapter 6 Precision oncology: nanoemulsions as pioneers in the delivery of anticancer agents, immunomodulators, and vaccines

  • Amrita Thakur and Gunjan Jeswani
Become an author with De Gruyter Brill
Micro and Nano Emulsion Technologies
This chapter is in the book Micro and Nano Emulsion Technologies

Abstract

Precision oncology represents a paradigm shift in cancer treatment, emphasizing tailored therapeutic strategies based on individual patient profiles. Among the innovative drug delivery systems revolutionizing this field, micro- and nanoemulsions have emerged as promising carriers for anticancer agents, immunomodulators, and vaccines. These colloidal systems offer several advantages, including enhanced solubility of poorly water-soluble drugs, targeted delivery, controlled release, and reduced systemic toxicity. This chapter delves into the design, formulation, and optimization of nanoemulsions, highlighting their physicochemical properties and how these contribute to improved therapeutic outcomes in oncology. Emphasis is placed on their role in delivering chemotherapeutic agents with precision, modulating immune responses for immunotherapy, and serving as platforms for cancer vaccines. The integration of these systems with advanced targeting ligands, imaging agents, and personalized medicine approaches is also explored, underscoring their transformative potential in cancer care. The chapter concludes with a discussion of current challenges, regulatory perspectives, and future directions for clinical translation.

Abstract

Precision oncology represents a paradigm shift in cancer treatment, emphasizing tailored therapeutic strategies based on individual patient profiles. Among the innovative drug delivery systems revolutionizing this field, micro- and nanoemulsions have emerged as promising carriers for anticancer agents, immunomodulators, and vaccines. These colloidal systems offer several advantages, including enhanced solubility of poorly water-soluble drugs, targeted delivery, controlled release, and reduced systemic toxicity. This chapter delves into the design, formulation, and optimization of nanoemulsions, highlighting their physicochemical properties and how these contribute to improved therapeutic outcomes in oncology. Emphasis is placed on their role in delivering chemotherapeutic agents with precision, modulating immune responses for immunotherapy, and serving as platforms for cancer vaccines. The integration of these systems with advanced targeting ligands, imaging agents, and personalized medicine approaches is also explored, underscoring their transformative potential in cancer care. The chapter concludes with a discussion of current challenges, regulatory perspectives, and future directions for clinical translation.

Downloaded on 15.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/9783111593654-007/html
Scroll to top button